Amgen 2000 Annual Report Download - page 45

Download and view the complete annual report

Please find page 45 of the 2000 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 47

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47

Corporate Office
One Amgen Center Drive
Thousand Oaks, California 91320 -1799
(805) 447-1000
SEC Form 10-K
A copy of the Companys Annual Report on Form 10-K for the year
ended December 31, 2000, filed with the Securities and Exchange
Commission, is available without charge upon written request to
Corporate Secretary, Amgen Inc., One Amgen Center Drive,
Thousand Oaks, California 91320 -1799; by calling (800) 84-AMGEN;
or by accessing the Companys web site at www.Amgen.com.
Transfer Agent and Registrar
American Stock Transfer & Trust Company
59 Maiden Lane
New York, New York 10038
Stockholder Inquiries
Inquiries related to stock transfers or lost certificates should
be directed to American Stock Transfer & Trust Company,
(800) 937-5449 or (212) 936-5100. General information regarding
the Company can be obtained by contacting Amgens investor
relations department, (805) 447-3352. Recent news releases and
other information can also be obtained by contacting Amgens
automated stockholder information line at (800) 84-AMGEN or by
accessing the Companys web site at www.Amgen.com.
Independent Auditors
Ernst & Young LLP, Los Angeles, California
Annual Meeting
The Annual Meeting will be held on Thursday, May 17, 2001, at
10:30 a.m. at the Beverly Hilton Hotel, 9876 Wilshire Boulevard,
Los Angeles, California 90210.
Price Range of Common Stock
The Companys Common Stock trades on The Nasdaq Stock
Market under the symbol AMGN. As of February 28, 2001, there
were approximately 17,000 holders of record of the Companys
Common Stock. No cash dividends have been paid on the
Common Stock to date, and the Company currently intends to
retain any earnings for development of the Companys business
and repurchases of its Common Stock.
The following table sets forth, for the fiscal periods indicated, the
range of high and low closing sales prices of the Common Stock
as quoted on The Nasdaq Stock Market for the fiscal years 2000
and 1999:
2000 1999
High Low High Low
4th Quarter $ 71.38 $ 54.13 $ 64.88 $ 37.84
3rd Quarter 78.00 64.94 43.78 29.50
2nd Quarter 70.38 51.31 40.00 26.16
1st Quarter 74.69 52.25 39.53 26.14
Trademarks Listed in This Report
Amgen, ARANESP
, EPOGEN®
,INFERGEN®
, NEUPOGEN®
, and STEMGEN®
are trademarks of Amgen Inc.
Hotlines
Amgen Customer Service Hotline (800) 28-AMGEN
Amgen Investor Materials Hotline (800) 84-AMGEN
Amgen Job Hotline (800) 446-4007
Amgen Professional Services Hotline (800) 77-AMGEN
Amgen Reimbursement Hotline (800) 272-9376
Amgen Safety Hotline (800) 835-2879
48
Corporate Information